Cited by 62Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroscience and Neuropharmacology Research

The effects of perturbed energy metabolism on the processing of amyloid precursor protein in PC12 cells

Webster, M.-T., Pearce, B. R., Bowen, D. M., Francis, P. T.·1998·Journal of Neural Transmission

Abstract

The mismetabolism of amyloid precursor protein (APP), favouring the production of A beta, is considered to be central to the pathogenesis of Alzheimer's disease (AD). However it remains to be established whether the causative factor is the reported toxicity of A beta or reduced production of secretory derivatives of APP which may have trophic or neuroprotective properties. One possible contributory factor to an imbalance in APP metabolism is the impaired cellular energy availability described in AD. The aim of this study was to investigate processing of APP-like proteins following inhibition of oxidative energy metabolism in PC12 cells. Under these conditions, intracellular and secreted APP-like proteins were significantly reduced. Treatment of energy perturbed cells with the lysosomotropic agent chloroquine restored intracellular concentrations of APP-like proteins to the control range, while the secretion was completely restored by activation of protein kinase C. These findings raise the possibility that energy related metabolic stress may lead to altered metabolism of APP-like proteins favouring a potentially amyloidogenic pathway. Furthermore, the observation that activation of PKC is able to overcome this potentially pathogenic process has important implications for treatment of AD with the current generation of cholinomimetic drugs, suggesting that such drugs may slow disease progression as well as improve cognitive dysfunction.

Integrity signals

Registry

Crossref · 10.1007/s007020050098

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mitochondria directly influence other AD-associated pathologies, particularly APP and Aβ homeostasis.

    “Data also argue mitochondria directly influence other AD-associated pathologies, and particularly APP and Aβ homeostasis.”
  • Whether Aβ changes precede either age-related or AD-related brain bioenergetic changes is less clear-cut.

    “Whether Aβ changes precede either age-related or AD-related brain bioenergetic changes is less clear-cut, especially since abundant data from human and cell-based studies either suggest or demonstrate bioenergetic factors regulate both APP processing and Aβ production [95–100].”

    From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [98]

  • Abundant data from human and cell-based studies either suggest or demonstrate bioenergetic factors regulate both APP processing and Aβ production.

    “Whether Aβ changes precede either age-related or AD-related brain bioenergetic changes is less clear-cut, especially since abundant data from human and cell-based studies either suggest or demonstrate bioenergetic factors regulate both APP processing and Aβ production [95–100].”

    From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [98]

  • COX inhibition and ATP depletion both reduced non-amyloidogenic, α secretase-mediated APP processing in cell culture experiments.

    “This was directly demonstrated in cell culture experiments in which COX inhibition and ATP depletion both reduced non-amyloidogenic, α secretase-mediated APP processing [95, 96, 98].”

    From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [98]

  • Bioenergetic metabolism affects APP processing and Aβ production.

    “Bioenergetic metabolism certainly affects APP processing and Aβ production.”

    From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [98]

The citation lists haven’t been fetched yet

References 49 · Cited by 62

Authors
Webster, M.-T., Pearce, B. R., Bowen, D. M., & Francis, P. T.
Affiliations
UCL Queen Square Institute of Neurology (GB)
Venue
Journal of Neural Transmission
Published
1998-11-04
Volume
105
Issue
8-9
Pages
839-853
ISSN
  • 0300-9564 (ISSN-L)
  • 1435-1463
OpenAlex
W2147691616
Cited by
62
References
49
Citations by year
2023: 2 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 7 · 2017: 4 · 2016: 4 · 2015: 2 · 2013: 1 · 2012: 3
FWCI
1.64
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Neural Transmission (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
amyloid precursor protein, APP processing, Alzheimer's disease, energy metabolism, oxidative stress, PC12 cells, chloroquine, lysosomotropic agents, protein kinase C, APP secretion, amyloid-beta, metabolic stress, cholinomimetic drugs
MeSH terms
Animals, Antimetabolites, Bradykinin, Chloroquine, Deoxyglucose, Energy Metabolism, Immunologic Techniques, Nucleotides, Oligomycins, Protein Processing, Post-Translational, Reference Values, Amyloid beta-Protein Precursor, PC12 Cells, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review